Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines

por Suda, Kenichi, Rozeboom, Leslie, Furugaki, Koh, Yu, Hui, Melnick, Mary Ann C., Ellison, Kim, Rivard, Christopher J., Politi, Katerina, Mitsudomi, Tetsuya, Hirsch, Fred R.
Publicado 2017

miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma

por Zhang, Wen Cai, Wells, Julie M., Chow, Kin-Hoe, Huang, He, Yuan, Min, Saxena, Tanvi, Melnick, Mary Ann, Politi, Katerina, Asara, John M., Costa, Daniel B., Bult, Carol J., Slack, Frank J.
Publicado 2019

Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer

por Adua, Sally J., Arnal-Estapé, Anna, Zhao, Minghui, Qi, Bowen, Liu, Zongzhi Z., Kravitz, Carolyn, Hulme, Heather, Strittmatter, Nicole, López-Giráldez, Francesc, Chande, Sampada, Albert, Alexandra E., Melnick, Mary-Ann, Hu, Bomiao, Politi, Katerina, Chiang, Veronica, Colclough, Nicola, Goodwin, Richard J. A., Cross, Darren, Smith, Paul, Nguyen, Don X.
Publicado 2022